Device Trial Radar · NCT04757753
Root Canal Obturation With a Ready-to-use Root Canal Sealer (PA1704) Versus BioRoot™ RCS: a Randomized Controlled Trial
Last checked: Nov 20, 2026Latest source record: Jun 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
160
Actual
Start
Nov 6, 2020
Primary completion
Aug 29, 2023
Study completion Dec 2026
Sponsor
- Lead sponsor
- SeptodontNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Slb Pharma
- First posted
- Feb 17, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study design is a multicentric randomized controlled non-inferiority trial. 160 subjects (teeth) requiring a primary or a secondary root canal treatment will be enrolled in 2 groups (80 in each group). The aim of the study is to assess the efficacy rate and the safety 2 years after root canal obturation undertaken using a ready-to-use calcium silicate sealer (PA1704) compared to the control calcium silicate sealer BioRoot™ RCS. Procedures of root canal treatment will be conventional and standardized for all investigational centers. The canals will be cleaned, shaped and then obturated using a calcium silicate sealer (the ready to use sealer PA1704 or BioRoot™ RCS) with a single cone technique or cold lateral condensation of gutta-percha. Follow-up assessments will be conducted at 6, 12 and 24 months in both groups. The performance and safety of the sealer PA1704 will also be evaluated at 3.5 and 5 years after surgery. Retroalveolar radiographs will be taken at each study visit. The preoperative, postoperative and follow-up clinical and radiographic data will be analyzed.
Conditions
- Root Canal Obturation
Interventions
ready-to-use root canal sealer: PA1704Device
The participant will be treated with the ready-to-use root canal sealer (PA1704) in combination with gutta percha.
root canal sealer: BioRoot™ RCSDevice
The participant will be treated with BioRoot™ RCS sealer in combination with gutta percha.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy Rate of Root Canal ObturationTime frame: 24 months post-treatment
Locations
5 sites in 2 countries. Site status is shown where the registry gives one.
Cliniques Universitaires Saint-Luc, Département de Médecine Dentaire et de Stomatologie
Brussels, Belgium
Centre de santé dentaire Flandre
Paris, France
Cabinet dentaire
Rennes, France
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.